血浆代谢组生物标志物与持续性耳鸣的关联:一项基于人群的病例对照研究
该研究基于护士健康研究(NHS)和NHS II的6477名女性,纳入488例持续性耳鸣病例和5989名对照,检测466种血浆代谢物,采用逻辑回归估计耳鸣与代谢物的关联。发现同型瓜氨酸、多种磷脂酰乙醇胺和甘油三酯与持续性耳鸣正相关,α-酮-β-甲基戊酸和乙酰丙酸负相关,提示代谢组学可能有助于理解耳鸣病理生理并识别治疗靶点。
要点
- 同型瓜氨酸(OR 1.32)及C38:6 PE(OR 1.24)等代谢物与持续性耳鸣正相关。
- α-酮-β-甲基戊酸(OR 0.68)和乙酰丙酸(OR 0.60)与持续性耳鸣负相关。
- 甘油三酯、磷脂酰乙醇胺类代谢物集与耳鸣正相关,溶血磷脂酰胆碱等负相关。
核心结论
- 该基于人群的病例对照研究识别出与持续性耳鸣显著相关的新血浆代谢物和代谢物类别,提示代谢组学研究可能有助于加深对耳鸣病理生理的理解并识别治疗靶点。
研究设计与样本
- 基于人群的病例对照研究,纳入6477名护士健康研究(NHS)和NHS II的女性参与者,均有代谢组学数据和耳鸣数据。
- 耳鸣发病和频率信息来自2009-2017年双年问卷;病例的代谢组学检测于2015-2021年进行,血样采集于参与者首次报告持续性耳鸣日期之后(NHS:1989-1999年和2010-2012年;NHS II:1996-1999年)。
- 共纳入488例持续性耳鸣病例和5989名对照,使用3种互补的液相色谱串联质谱方法检测466种血浆代谢物。
- 数据分析于2022年1月24日至2023年1月14日进行。
主要发现
- 与无耳鸣对照相比,持续性耳鸣患者年龄稍大(53.0岁 vs 51.8岁),更可能已绝经、使用口服绝经后激素治疗,以及基线时患有2型糖尿病、高血压和/或听力损失。
- 与对照相比,同型瓜氨酸(OR 1.32;95%CI 1.16-1.50)、C38:6磷脂酰乙醇胺(PE;OR 1.24;95%CI 1.12-1.38)、C52:6甘油三酯(TAG;OR 1.22;95%CI 1.10-1.36)、C36:4 PE(OR 1.22;95%CI 1.10-1.35)、C40:6 PE(OR 1.22;95%CI 1.09-1.35)和C56:7 TAG(OR 1.21;95%CI 1.09-1.34)与持续性耳鸣正相关。
- α-酮-β-甲基戊酸(OR 0.68;95%CI 0.56-0.82)和乙酰丙酸(OR 0.60;95%CI 0.46-0.79)与持续性耳鸣负相关。
- 在代谢物类别中,甘油三酯(NES 2.68)、磷脂酰乙醇胺(NES 2.48)和甘油二酯(NES 1.65)与持续性耳鸣正相关;磷脂酰胆碱缩醛磷脂(NES -1.91)、溶血磷脂酰胆碱(NES -2.23)和胆固醇酯(NES -2.31)与持续性耳鸣负相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Persistent tinnitus is common, disabling, and difficult to treat. OBJECTIVE: To evaluate the association between circulating metabolites and persistent tinnitus. DESIGN, SETTING, AND PARTICIPANTS: This was a population-based case-control study of 6477 women who were participants in the Nurses' Health Study (NHS) and NHS II with metabolomic profiles and tinnitus data. Information on tinnitus onset and frequency was collected on biennial questionnaires (2009-2017). For cases, metabolomic profiles were measured (2015-2021) in blood samples collected after the date of the participant's first report of persistent tinnitus (NHS, 1989-1999 and 2010-2012; NHS II, 1996-1999). Data analyses were performed from January 24, 2022, to January 14, 2023. EXPOSURES: In total, 466 plasma metabolites from 488 cases of persistent tinnitus and 5989 controls were profiled using 3 complementary liquid chromatography tandem mass spectrometry approaches. MAIN OUTCOMES AND MEASURES: Logistic regression was used to estimate odds ratios (ORs) of persistent tinnitus (per 1 SD increase in metabolite values) and 95% CIs for each individual metabolite. Metabolite set enrichment analysis was used to identify metabolite classes enriched for associations with tinnitus. RESULTS: Of the 6477 study participants (mean [SD] age, 52 [9] years; 6477 [100%] female; 6121 [95%] White individuals) who were registered nurses, 488 reported experiencing daily persistent (≥5 minutes) tinnitus. Compared with participants with no tinnitus (5989 controls), those with persistent tinnitus were slightly older (53.0 vs 51.8 years) and more likely to be postmenopausal, using oral postmenopausal hormone therapy, and have type 2 diabetes, hypertension, and/or hearing loss at baseline. Compared with controls, homocitrulline (OR, 1.32; (95% CI, 1.16-1.50); C38:6 phosphatidylethanolamine (PE; OR, 1.24; 95% CIs, 1.12-1.38), C52:6 triglyceride (TAG; OR, 1.22; 95% CIs, 1.10-1.36), C36:4 PE (OR, 1.22; 95% CIs, 1.10-1.35), C40:6 PE (OR, 1.22; 95% CIs, 1.09-1.35), and C56:7 TAG (OR, 1.21; 95% CIs, 1.09-1.34) were positively associated, whereas α-keto-β-methylvalerate (OR, 0.68; 95% CIs, 0.56-0.82) and levulinate (OR, 0.60; 95% CIs, 0.46-0.79) were inversely associated with persistent tinnitus. Among metabolite classes, TAGs (normalized enrichment score [NES], 2.68), PEs (NES, 2.48), and diglycerides (NES, 1.65) were positively associated, whereas phosphatidylcholine plasmalogens (NES, -1.91), lysophosphatidylcholines (NES, -2.23), and cholesteryl esters (NES,-2.31) were inversely associated with persistent tinnitus. CONCLUSIONS AND RELEVANCE: This population-based case-control study of metabolomic profiles and tinnitus identified novel plasma metabolites and metabolite classes that were significantly associated with persistent tinnitus, suggesting that metabolomic studies may help improve understanding of tinnitus pathophysiology and identify therapeutic targets for this challenging disorder.
引用
- Zeleznik OA, Welling DB, Stankovic K, et al. Association of Plasma Metabolomic Biomarkers With Persistent Tinnitus: A Population-Based Case-Control Study. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36928544. doi:10.1001/jamaoto.2023.0052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。